Clinical Trial Update: Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)

View source ↗

Summary

A completed clinical trial evaluating the performance of vibegron in participants with overactive bladder. The study was sponsored by Urovant Sciences GmbH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Vibegron (vibegron)

Snippet

Sponsor: Urovant Sciences GmbH | Conditions: Overactive Bladder | Status: COMPLETED